Effects of alteplase on survival after ischaemic stroke (IST-3): 3 year follow-up of a randomised, controlled, open-label trial

Eivind Berge, Geoffrey Cohen, Melinda B Roaldsen, Erik Lundström, Eva Isaksson, Ann-Sofie Rudberg, Karsten Bruins Slot, John Forbes, Joel Smith, Jonathan Drever, Joanna M Wardlaw, Richard I Lindley, Peter A G Sandercock, William N Whiteley

Open source

DOI
10.1016/s1474-4422(16)30139-9
Published
2016-09
Container
The Lancet Neurology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s1474-4422-16-30139-9,
  title = {Effects of alteplase on survival after ischaemic stroke (IST-3): 3 year follow-up of a randomised, controlled, open-label trial},
  author = {Eivind Berge and Geoffrey Cohen and Melinda B Roaldsen and Erik Lundström and Eva Isaksson and Ann-Sofie Rudberg and Karsten Bruins Slot and John Forbes and Joel Smith and Jonathan Drever and Joanna M Wardlaw and Richard I Lindley and Peter A G Sandercock and William N Whiteley},
  year = {2016},
  journal = {The Lancet Neurology},
  doi = {10.1016/s1474-4422(16)30139-9},
  url = {https://doi.org/10.1016/s1474-4422(16)30139-9}
}

RIS

TY  - JOUR
TI  - Effects of alteplase on survival after ischaemic stroke (IST-3): 3 year follow-up of a randomised, controlled, open-label trial
AU  - Eivind Berge
AU  - Geoffrey Cohen
AU  - Melinda B Roaldsen
AU  - Erik Lundström
AU  - Eva Isaksson
AU  - Ann-Sofie Rudberg
AU  - Karsten Bruins Slot
AU  - John Forbes
AU  - Joel Smith
AU  - Jonathan Drever
AU  - Joanna M Wardlaw
AU  - Richard I Lindley
AU  - Peter A G Sandercock
AU  - William N Whiteley
PY  - 2016
JO  - The Lancet Neurology
DO  - 10.1016/s1474-4422(16)30139-9
UR  - https://doi.org/10.1016/s1474-4422(16)30139-9
ER  - 

APA

Berge, E., Cohen, G., Roaldsen, M. B., Lundström, E., Isaksson, E., Rudberg, A., Slot, K. B., Forbes, J., Smith, J., Drever, J., Wardlaw, J. M., Lindley, R. I., Sandercock, P. A. G., & Whiteley, W. N. (2016). Effects of alteplase on survival after ischaemic stroke (IST-3): 3 year follow-up of a randomised, controlled, open-label trial. The Lancet Neurology. https://doi.org/10.1016/s1474-4422(16)30139-9

Source records